Home › Chemotherapy › Chemotherapy Drug Costs in India — What Drives the Price Difference

Treatment costs

Chemotherapy Drug Costs in India What Drives the Price Difference

Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026

Chemotherapy drug prices in India vary enormously — from a few hundred rupees for older generic drugs to several lakh rupees per infusion for newer biological agents. The cost you pay depends on which drugs are in your protocol, whether generics are available for them, and how your treatment is funded.

Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026

Prescription-only medicine.

Chemotherapy is a prescription-only treatment administered under specialist supervision in a hospital or day-care oncology unit. Nothing on this page can be used to start, adjust, or stop any drug — those decisions belong to a qualified oncologist who has reviewed your case in full. It is not suitable for everyone — see who this is not for below.

Talk to an oncologist

Leave your details and a member of the oncology team will call you back to answer questions about your treatment plan.

No charge for the call, and no obligation to book anything.

412Chemotherapy pages, written and reviewed

17Oncologists on the panel

10Centres across Hyderabad

41Locations across two states

In short

Chemotherapy drug prices in India range from a few hundred rupees per vial for older generics to several lakh rupees per cycle for newer biological agents. What you pay depends on the molecule, whether a generic or biosimilar is available, and your regimen. Only your oncologist and pharmacist can give an accurate figure once your protocol is set.

In detail

Why do chemotherapy drugs cost such different amounts?

The oldest cytotoxic drugs — molecules like cyclophosphamide, fluorouracil, cisplatin, methotrexate, and doxorubicin — have been off-patent for decades. Multiple Indian manufacturers produce them, which keeps prices relatively low.

Newer biological agents, including monoclonal antibodies like rituximab, trastuzumab, and bevacizumab, are far more expensive to manufacture and took longer to lose patent protection. Even where CDSCO-approved biosimilars are now available, the cost per infusion remains much higher than older cytotoxics.

As a rough guide for 2026: older generic cytotoxics range from a few hundred to a few thousand rupees per vial. Newer biological therapies can run to tens of thousands per infusion. These are indicative market figures — your actual cost depends on your specific protocol and where you are treated.

Checklist

What should you check before comparing chemotherapy drug costs?

Ask for the full protocol name — multi-drug regimens and the total number of cycles matter more than any single vial price.
Ask whether a generic or biosimilar is available in India for each drug in your protocol.
Check whether your health insurance or government scheme covers the drugs prescribed.
Find out whether a Jan Aushadhi pharmacy near your treatment centre stocks any of your drugs.
Confirm whether the quoted price includes pharmacy margins, administration fees, and supportive drugs, or just the drug itself.
Ask for a written cost breakdown naming every drug, the number of vials per cycle, and the planned number of cycles.

Eligibility

Who chemotherapy may not be suitable for

Chemotherapy is not appropriate for everyone, and eligibility is always decided by an oncologist on the individual case. Groups for whom specific regimens may not be suitable include:

People with severely reduced kidney or liver function, which affects how the body processes and clears most drugs
People with very low blood counts before treatment begins, raising the risk of serious infection and bleeding
People with active, uncontrolled serious infection
People with significantly reduced heart function, particularly for regimens that include anthracycline drugs
People in very poor general health where the burden of treatment outweighs likely benefit
People who carry certain genetic variants affecting drug metabolism, such as DPD deficiency with fluorouracil-based regimens

In pregnancy, many regimens are contraindicated — especially in the first trimester. Your oncologist will review blood results, organ function, performance status, and your full medical history before recommending any regimen.

Want to talk this through with an oncologist?

Leave your number and an oncology coordinator will call you back at a time that suits you.

Step by step

How do you find out what your chemotherapy will actually cost?

Confirm your protocol

Your oncologist gives you the protocol name, the drugs involved, and the number of cycles planned. Without this, no cost comparison is meaningful.

Ask the hospital pharmacist for a breakdown

The pharmacist can show you the current cost of each drug, whether a generic is stocked, and what administration charges apply.

Ask about generic and biosimilar options

For most older drugs, your oncologist can prescribe a CDSCO-approved generic. For some newer biologics, an approved biosimilar may be available at lower cost.

Check your insurance or scheme coverage

Contact your insurer or scheme office with your diagnosis code and the drug names. Ask for written confirmation of what is covered before treatment starts.

Compare total cycle cost, not vial cost

A cheaper vial that requires more cycles, or more vials per cycle, may cost more overall. Ask for the total estimated cost across all planned cycles.

In detail

Are there government schemes that make chemotherapy cheaper?

The Pradhan Mantri Jan Aushadhi Pariyojana runs pharmacies across India stocking generic medicines — including some chemotherapy drugs — at significantly lower prices than retail. Ask at your treatment centre whether a Jan Aushadhi pharmacy is nearby.

PM-JAY (Ayushman Bharat) covers hospitalisation and some chemotherapy for eligible families up to a defined annual ceiling. State-level schemes in Telangana and Andhra Pradesh add further coverage for some patients. Your hospital billing team or social worker can check your eligibility.

Some manufacturers of high-cost drugs run patient assistance programmes. Your oncologist or the hospital's financial counsellor can tell you whether one applies to the drug prescribed for you.

Worth knowing

Did you know?

India is one of the world's largest producers of generic medicines. For older chemotherapy drugs that are off-patent, Indian-manufactured generics must pass the same bioequivalence tests as the originator product.

Choosing a CDSCO-approved generic is not choosing a lower-quality medicine — it is choosing the same molecule at a lower price.

Source: Central Drugs Standard Control Organisation (CDSCO)

Still have a question about your treatment? Tell us what is on your chart and an oncologist will explain what it means for you, what to expect and what your schedule is likely to look like.

Talk to an oncologist 1800 202 8726

Common questions

Frequently asked questions

Why does the same drug cost different amounts at different hospitals?

The same molecule can be priced differently depending on whether the hospital stocks the branded originator or an Indian generic, the volume discount the hospital negotiates with its supplier, and whether administration costs are bundled into the drug price. A two- or three-fold difference for the same active ingredient is not unusual. When comparing quotes, confirm you are comparing like for like — same manufacturer version, same number of vials, same cycle count.

Are generic chemotherapy drugs as effective as branded ones?

Yes, when the generic holds CDSCO approval. Generic approval requires proof that the drug contains the same active ingredient at the same concentration and behaves the same way in the body. For older cytotoxic drugs — the backbone of most regimens — Indian generics dominate the market and are what most patients already receive as standard care.

What is a biosimilar and is it safe to use instead of the original?

A biosimilar is a biological medicine shown to be highly similar to an approved originator. Unlike small-molecule generics, biological drugs cannot be copied exactly because of their size and complexity, so biosimilars go through additional clinical studies before CDSCO approval. Approved biosimilars for cancer treatment have been studied in patients and found comparable in safety and activity to the originator. Your oncologist will tell you whether an approved biosimilar is appropriate for your specific cancer and stage.

Does health insurance cover chemotherapy drugs?

It depends on your policy. Private health insurance policies vary — some cover day-care chemotherapy in full, others have sub-limits or exclude specific drugs. Government schemes like PM-JAY cover hospitalisation and some chemotherapy for eligible families up to a defined ceiling. Before your first treatment, share your diagnosis and proposed protocol with your insurer or scheme office and ask for written confirmation of what is covered. Do this before, not after, treatment starts.

How do I access chemotherapy through PM-JAY or a state government scheme?

Tell your hospital billing team before your first treatment that you are enrolled in PM-JAY or a state scheme. They will check whether your diagnosis and proposed regimen fall under an applicable package and that the hospital is empanelled. A social worker in the oncology unit can usually help with paperwork. Once a claim is submitted correctly, the cost covered by the scheme is settled between the hospital and the scheme administrator — you pay only whatever is not covered.

Can I ask my oncologist to prescribe a cheaper drug?

You can — and should — ask whether a generic or biosimilar version of your prescribed drug is available and clinically suitable. For older cytotoxics, a CDSCO-approved generic is usually equivalent. For newer biologics, an approved biosimilar may be an option. What you should not do is reduce cycles, skip doses, or substitute a different drug on cost grounds without telling your oncologist. Changes like these affect how well treatment works and must only happen with clinical guidance.

Who would be treating you

The medical oncologists on the CION panel

Chemotherapy is prescribed, dosed and supervised by a medical oncologist. These are the six on the CION panel.

Dr. Naresh Gundu

Medical Oncologist

MBBS · DNB Internal Medicine (Sir Gangaram, New Delhi) · DM Medical Oncology (AIIMS)

Call Book appointment

Dr. C. Raghavendra Reddy

Medical Oncologist

MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Kukatpally

Call Book appointment

Dr. Bharati Devi Gorantla

Medical Oncologist

MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK)

Call Book appointment

Dr. Owais Mohammed

Medical Oncologist

Call Book appointment

Dr. T. Raghavender Reddy

Medical Oncologist

MBBS · DM (Medical Oncology) · MD (Radiation Oncology) · L.B. Nagar

Call Book appointment

Dr. N. Kiranmayee

Medical Oncologist

Call Book appointment

Which oncologist you see depends on the centre nearest you and on what your treatment involves. Tell us where you are and we will point you to the closest.

Talk it through

Reading about a medicine is not the same as being told what to expect

This page explains what the medicine does in general. What it cannot tell you is how your own regimen was chosen, what your schedule looks like, or which of these effects apply to you — that needs your reports and a conversation.

Free first consultation Second opinion on an existing plan 10 centres across Hyderabad

Speak to an oncologist

Share your details and the team will call you back to arrange a consultation or a second opinion.

Bring your reports if you have them. If you do not, come anyway.

list of links to other editorial pages, which base contract s2.1 permits explicitly. It contains no form, no phone number and no CTA button, so it does not turn this page into an advertisement. Generated by scripts/hub_update.py --include-out. -->

Full index